Lizzo Fires Back at Ozempic Critics: ‘This S**t Is Hard'
Lizzo shared with writer Jessica Herndon that she's recently received questions from fans, like, 'Are you taking Ozempic?' and 'What happened when you said it's okay to be fat?' This is not to say that the artist seeks to shade those who turn to GLP-1 drugs in their healthcare journeys. She said, 'If I did all of this on Ozempic....I would be just as proud of myself, because this s**t is hard.'
For the 'About Damn Time' singer, this wasn't a weight loss journey, but a weight release journey. Because, as Lizzo sees it, she didn't actually lose anything. 'It's okay to release weight...[and] it's okay to gain weight after you've released weight,' she says.
In January, Lizzo posted photos to her Instagram wearing workout gear paired with an ecstatic caption. 'I reached my weight release goal,' she wrote, adding a motivational message for fans about achieving their own goals.
'I wanted to be 'big-girl skinny,'' she tells Women's Health. 'Every big girl knows what I'm talking about. Big-girl skinny is 250 pounds.' This meant a balance of feeling like herself while reducing back pain and health concerns she struggled with. The change, she explains, came from consistent exercise and a nutritious diet with lean proteins and vegetables. Each week, she performs a mix of strength training and cardio for three days, and dedicates two days to 45-minute cardio workouts. It wasn't about chasing thinness—only feeling better in her body, on her terms.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
Billionaire Reid Hoffman Bets $12M On This AI Brain Scanner To Rival Neuralink — Without Surgery Or Drugs
Sanmai Technologies, a stealthy neurotechnology startup, has raised $12 million in a Series A round led by LinkedIn co‑founder Reid Hoffman, who will also join its board of directors, Bloomberg reports. Sanmai is developing a non‑invasive, AI‑guided focused ultrasound headset to treat mental health disorders and improve cognitive function. The device is designed to sell for under $500, making clinic‑grade brain stimulation accessible at home. According to Bloomberg, this funding aligns with growing interest from billionaire investors in cutting‑edge brain science, such as Coinbase co‑founder Fred Ehrsam's Nudge and Elon Musk's Neuralink. Don't Miss: Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. GoSun's Breakthrough Rooftop EV Charger Already Has 2,000+ Units Reserved — Sanmai's headset uses low-intensity transcranial-focused ultrasound to target specific brain regions associated with conditions such as anxiety, depression, pain, epilepsy, and tremors, Bloomberg says. According to a LinkedIn post by neurotechnology research scientist and first employee at Sanmai Sharena Rice, an integrated AI companion guides treatment and helps determine which protocols are most effective, adapting the stimulation to each user's skull structure and brain activity. The system compensates for skull variations and dynamically adjusts ultrasound parameters to maximize efficacy and safety. Rice confirmed in the LinkedIn post that combining AI with focused ultrasound enables precise deep‑brain stimulation without surgery. Sanmai has developed an early clinical prototype of its device for generalized anxiety disorder. Bloomberg says that the company is also in discussions with the Food and Drug Administration as it prepares for formal clinical trials and regulatory review. Sanmai aims to validate its technology in clinical settings before expanding toward broader consumer availability. "I thought it was very cool that it gives you a new instrument for dealing with a whole wide variety of brain things which are otherwise very difficult to deal with," Hoffman told Bloomberg. "Your toolset for dealing with things that are going wrong in the brain is very limited." Trending: Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — Sanmai's low-intensity focused ultrasound system is designed to deliver energy through the skull, reaching precise areas of brain tissue without breaking the skin. According to Bloomberg, the technology, which stimulates neural activity by directing sound waves to specific targets, reflects more than ten years of academic research now transitioning into regulated clinical testing. Sanmai founder Jay Sanguinetti began exploring brain stimulation as a graduate student, observing its effects on Parkinson's patients during invasive procedures. That experience laid the foundation for his pursuit of a safer, scalable alternative. "I saw every patient's life changed," he told Bloomberg. "But I got kind of bit by the bug of like, 'How do you do this but non-invasively and at scale?'" The company's eight-person team, operating largely in stealth until now, is preparing for broader trials after initial testing began at a Sunnyvale, California clinic for patients with generalized anxiety disorder. While Sanmai's goal is to create a home-use device priced below $500, Bloomberg says that the path forward requires individualized calibration, including magnetic resonance imaging scans and real-time adjustments to ultrasound dosage, before moving beyond clinical settings. "The way to do this safely and at scale is to first go through the clinics," Sanguinetti told Bloomberg. "Then leverage that data to go out to the consumer."Hoffman's investment in Sanmai comes at a time when private funding is playing an increasingly critical role in neuroscience innovation. With the U.S. government reducing its support for biomedical research, wealthy individuals like Hoffman are stepping in to advance technologies aimed at treating mental health disorders and neurological conditions, Bloomberg reports. At a recent neuromodulation conference near Washington, dozens of scientists and clinicians voiced concern over federal funding cuts, including proposed reductions to the National Institutes of Health and the departure of more than 143 staffers from its neurological division. In this tightening environment, Bloomberg says that investors like Hoffman, who previously backed OpenAI, are becoming central to the development of next-generation brain technologies. "Non-invasive is a much less risky approach for a significant benefit," Hoffman told Bloomberg. "The risk and difficulties in invasive strike me as very difficult to navigate and will take years, decades maybe." Read Next: Here's what Americans think you need to be considered wealthy. Image: Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? APPLE (AAPL): Free Stock Analysis Report TESLA (TSLA): Free Stock Analysis Report This article Billionaire Reid Hoffman Bets $12M On This AI Brain Scanner To Rival Neuralink — Without Surgery Or Drugs originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.
CNN
16 minutes ago
- CNN
Lea Thompson believes the first ‘Back to the Future' film is ‘a perfect screenplay'
It's been 40 years since Marty McFly hopped into that juiced up DeLorean. One of the stars of 'Back to the Future' remembers it fondly. Lea Thompson reflected on the film in which she played Lorraine, the mother of Marty, played by Michael J. Fox, in a recent interview with People. Thompson was asked which of the three movies in the franchise was her favorite. 'For me, it's 'Back to the Future: 1' because it's just a perfect screenplay. And as a director, I can appreciate the conciseness of it.' 'And the truth is that 'Back to the Future: 2' and 3 were supposed to be kind of like one movie, and then they spread it out into two,' she said. 'So, it wasn't constructed in the same way as 'Back to the Future' was. So I just think it's a perfect screenplay.' According to Thompson, now 64, 'when we made 'Back to the Future,' we didn't even think we were going to make a sequel.' 'There was no sequel deal. There was no concept of that,' Thompson said. 'I mean, that's how long ago it was.' The science fiction film was directed by Robert Zemeckis and written by Zemeckis and Bob Gale. Steven Spielberg served as Executive Producer. Thompson said she also enjoys how love for the film, which first debuted in movie theaters July 3, 1985, has spanned different generations. 'It's really a joy when we look out in the audience when we're doing one of those talkbacks and half the people weren't even born when the movie came out,' she said. 'I mean, that's exceptionally cool.'
Yahoo
20 minutes ago
- Yahoo
3 weird ways to keep your brain healthy — one you can do in the shower
No need to overthink brain health! Our noggins take a floggin' with age, leading to reduced brain volume, less effective communication between neurons and decreased blood flow. These changes can affect learning, memory, processing speed and other cognitive functions. Now, you probably already know that eating a healthy diet, exercising regularly, getting adequate sleep, managing stress and staying socially connected can help keep brains young. There are also some offbeat strategies to engage your brain — you can learn an instrument, use your non-dominant hand for tasks and take a different route home. Harvard-trained neuroscientist Kevin Woods — director of science at a music streaming service designed to influence brainwave activity — has three other simple suggestions to complement healthy routines. No brainstorm required. Chewing gum can feed the brain in a number of ways, though the exact mechanisms are unclear. Some studies propose that chewing gum increases blood flow to the brain, which means more oxygen and glucose for the prefrontal cortex and hippocampus, areas vital for memory and learning. This increased blood flow can also enhance focus and attention and reduce stress and anxiety. As for types of gum, Woods told The Post that 'it should be a gum with decent flavor that doesn't fade too quickly — and one that doesn't fall apart over time.' A dentist might recommend a sugar-free gum that doesn't harm teeth. There could be an even better, if not unconventional, option. A recent study found that chewing hard substances like a wood pencil can boost levels of the antioxidant glutathione in the brain — chewing gum did not provide the same effect. If you're worried about splinters, tooth damage and digestive issues with wooden material, leave it to beavers. 'Backward walking enhances brain health by challenging the brain, focusing attention and strengthening neural connections while potentially forming new pathways,' Woods said. 'Studies have found that backward walking increases cognitive control and even memory recall,' he added. Also known as retro walking, this practice can improve balance, coordination and posture, strengthen certain muscles, reduce lower back pain and burn more calories than walking forward. Experts recommend starting slowly, choosing a path free of obstacles and uneven pavement, keeping the head and torso upright, engaging the core, stepping toes first and being mindful of surroundings. Humming can ease stress and promote relaxation by stimulating the vagus nerve, a complex network of over 200,000 fibers that connects the brain and major organs. Research indicates that humming can also increase nitric oxide levels in the nasal cavity, potentially improving blood flow to the brain and elevating mood. 'Studies on choir singers show enhanced heart rate variability and cognitive function,' Woods explained. 'Plus, the breath control required for sustained notes exercises the same neural networks involved in attention regulation.' Woods recommends doing these three activities often, finding a consistent routine that works for you. Since the brain is the control center for thinking, feeling and acting, taking care of it is crucial for overall health and well-being. 'While science can tell us useful things to try, to some extent, different brains need different things to focus best,' Woods said. 'What you find helpful, someone else may find distracting,' he added. 'So don't be afraid to test what works best for you!'
